NCT06650527 Effect of Cognitive Empathy Training on Dementia Caregivers
| NCT ID | NCT06650527 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Emory University |
| Condition | Caregivers of People Living With Dementia |
| Study Type | INTERVENTIONAL |
| Enrollment | 118 participants |
| Start Date | 2025-02-13 |
| Primary Completion | 2028-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 118 participants in total. It began in 2025-02-13 with a primary completion date of 2028-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this project is to investigate the effect of cognitive empathy training on mental health, inflammation, and immune function in caregivers of people living with dementia (PLWD), and to examine the underlying psychological and neurobiological mechanisms. The primary aim is to establish the effectiveness of cognitive empathy training in improving caregiver mental health and immune function, and in decreasing caregiver inflammation The secondary aim is to investigate the psychological and neurobiological mechanism by which cognitive empathy training improves caregiver well-being
Eligibility Criteria
Inclusion Criteria: * Caregivers must live with their care recipient * Caregivers must have a Zarit Burden Scale score of 19 or higher * Caregivers must have no plans to move their care recipient to an institutional setting within the next year * Caregivers must be able to read and write English * Care recipient not in hospice * Access to a mobile phone that can take and email photographs Exclusion Criteria: * Subjects with a history of seizures or other neurological disorders, alcoholism, or any other substance abuse * Subjects with a history of psychiatric illness (excluding depression and anxiety disorders) will also be excluded * Subjects with a history of head trauma based on Survey * Subjects with MRI contra-indications
Contact & Investigator
James Rilling, PhD
PRINCIPAL INVESTIGATOR
Emory College of Arts & Sciences
Frequently Asked Questions
Who can join the NCT06650527 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Caregivers of People Living With Dementia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06650527 currently recruiting?
Yes, NCT06650527 is actively recruiting participants. Contact the research team at jrillin@emory.edu for enrollment information.
Where is the NCT06650527 trial being conducted?
This trial is being conducted at Atlanta, United States, Atlanta, United States, Atlanta, United States.
Who is sponsoring the NCT06650527 clinical trial?
NCT06650527 is sponsored by Emory University. The principal investigator is James Rilling, PhD at Emory College of Arts & Sciences. The trial plans to enroll 118 participants.